title: Serum methylglyoxal level and its association with oxidative stress and disease severity in patients with psoriasis.
abstract: Psoriasis vulgaris (PV), a chronic inflammatory skin disease, is a condition of increased oxidative stress (OxS). However, interest related to oxidative and carbonyl stress damages to proteins, such as the formation of advanced glycation end products (AGEs) and their precursor molecule methylglyoxal (MG) has been modest. The objective of this study was to compare the systemic levels of OxS markers in patients with PV and healthy controls (Co) and to investigate their correlation with the serum level of MG. Total peroxide concentration (TPX) and total antioxidant capacity (TAC) were estimated by means of spectrophotometry. The TPX and TAC ratio was regarded as OxS index (OSI). MG level was determined using ELISA. Compared to Co, patients with PV had significantly increased blood levels of TPX (P < 0.0001), OSI (P < 0.0001), and MG (P = 0.01), and lower TAC levels (P < 0.0001). Increase in body mass index (BMI) appeared to contribute to this imbalance as TAC levels decreased with increasing BMI (r = -0.252, P < 0.01). Increased TPX concentration was associated with higher serum level of MG (r = 0.610, P = 0.004), the latter being positively correlated with psoriasis area and severity index (r = 0.577, P = 0.008). In performed multivariate regression analysis, TPX, TAC, and OSI were all significant predictors of MG level. Our study gave further proof of increased systemic psoriasis-related OxS. MG serum level, reflecting simultaneously OxS as well as carbonyl stress status, could be used as a marker of disease activity in clinical trials while looking for new systemic therapies for psoriasis.
authors: Clinic of Dermatology, University of Tartu, 31 Raja St, 50417, Tartu, Estonia. Sirje.Kaur@kliinikum.ee
authors: Sirje
authors: S
authors: Kaur
authors: Kersti
authors: K
authors: Zilmer
authors: Vambola
authors: V
authors: Leping
authors: Mihkel
authors: M
authors: Zilmer
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000032:analysis; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D018384:Oxidative Stress; D010545:Peroxides / Q000097:blood; D050050:Protein Carbonylation; D011565:Psoriasis / Q000097:blood* / Q000175:diagnosis; D011765:Pyruvaldehyde / Q000097:blood*; D012307:Risk Factors; D012720:Severity of Illness Index; D013053:Spectrophotometry; D055815:Young Adult
chemical_list: D000975:Antioxidants; D015415:Biomarkers; D010545:Peroxides; D011765:Pyruvaldehyde